Bristol Myers Squibb is warming up for the FIFA World Cup 2026 with a new media campaign, launching its “Won’t Lose” ad ahead ...
After topping up its long-running operations in Puerto Rico with plans for a $650 million investment last year, Amgen is ...
For the first time in its 16-year analysis of the pharma industry, Deloitte found obesity drugs are the largest contributor to late-stage pipeline value, overtaking longtime leader oncology. The ...
A strategic marketing lead at CDMO Axplora, Arsalan Khan is also a chemical and pharmaceutical engineer, a published author and an avid tennis player. | Rising Stars: A strategic marketing lead at ...
Arvinas and Pfizer are the first to take a PROteolysis TArgeting Chimera (PROTAC) therapy across the FDA finish line, opening ...
Shortly after laying out $75 million upfront for Corstasis Therapeutics and its congestive heart failure edema drug Enbumyst, ...
A surprise interim trial miss in ivonescimab’s closely watched Harmoni-3 trial has sent Summit Therapeutics’ shares tumbling, ...
Four years after gaining FDA approval for Auvelity to treat major depressive disorder (MDD), Axsome Therapeutics has tacked ...
Looking to clarify its expectations on manufacturer responses following inspections, the FDA earlier this year unveiled, for ...
Unionized workers at fast-growing South Korean CDMO Samsung Biologics kicked off a planned general strike on Friday, ...
Sun Pharma will acquire Organon for $11.75 billion. Astellas projects Xtandi sales to decline in fiscal year 2026. | Sun ...
Already the largest biopharma company in India, generics powerhouse Sun Pharma has doubled in size with its acquisition (PDF) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results